Cluster buying
No cluster buys on today's tape
A cluster buy — several insiders buying the same stock at once — is rare. When one appears, it leads this page.
Same filings. Three ways in.
Every plan reads the same SEC stream — what changes is how much of the analysis on top of it you get. The live tape below is free, forever.
Read the tape
Free
Every Form 4 as it clears EDGAR, with the cluster and sentiment reads on top. No card, no trial clock.
- Live Form 4 feed, unthrottled
- Cluster-buy badges and sentiment charts
- Top 3 of the conviction leaderboard
- Most Watched — the popular-companies board, in full
- Top 5 names by off-exchange ATS volume
- The 6 most recent congressional filings
- The 2 strongest proven-buyer records
- One setup from each convergence matrix
- Company pages for every tracked ticker
$0forever
The whole signal
Pro
Everything above the fold plus the parts that take real work to compute — track records, planned sales, and alerts that keep watching after you close the tab.
- Proven Buyers — every current buyer scored on their own record
- 10b5-1 regime-break alerts when a scheduled seller hand-times
- Server-side Telegram alerts, running through the trading day
- Form 144 planned sales — sizes, values and intended dates
- Executive track records: 90-day returns vs the S&P 500
- Full cluster-buy radar across every issuer in the stream
- The complete conviction leaderboard with score breakdowns
- Buy/sell volume, Bull-Bear ratio and sector flow analytics
- Full dark-pool venue detail and the whole congressional feed
- Popular Investors: 128 verified managers and their books
- Unlimited watchlists and CSV export of any filtered view
$45per month
Billed monthly. Cancel any time.
Starts with a 3-day free trial
Best value
Same thing, cheaper
Pro Annual
The identical product on one charge instead of twelve. Nothing extra is unlocked — you are buying the same access at a lower rate.
- Everything in Pro, with nothing held back
- Save $240 a year (44%)
- One renewal a year instead of twelve
- Effective rate of $25.00 a month
- Against $540.00 for twelve monthly charges
- Cancel any time — access runs to the end of the year you paid for
$300per year
Save $240 a year (44%) · works out at $25.00/mo
Starts with a 3-day free trial
Streaming from SEC EDGARForm 4 · Live
Insider Trading & Sentiment Dashboard
Every Form 4 the moment it clears EDGAR — parsed, priced and scored for cluster-buy conviction. No API key, no delay, straight from the primary source.
Last sync —(cached)
1350 filings · 120 transactions · 1054 insiders
Today
The signals worth your attention right now, in plain English
Trading-plan break
Scanning filing histories…
Most executive sales run on 10b5-1 autopilot, scheduled months ahead. The moment one steps outside that plan and hand-times a sale, it appears here.
Largest open-market buy
bought $34.5M of
10% Owner at REPUBLIC SERVICES, INC., buying stock with their own money — the only kind of insider trade that costs the insider anything. Filed Sep 01, 2026.
Headline risk
No flagged headlines
The news stream is quiet on the bearish side. Headlines that threaten names on the tape get flagged here.
The depth behind these cards is Pro: planned-sale sizes and dates, executive track records, the full setup matrices, and server-side Telegram alerts — proven-buyer, plan-break and watchlist pings — watched through the trading day, even with the tab closed.
$45/moor $300/yr
New here? Company insiders must report their own trades to the SEC within two days — this terminal streams those filings live. Green means an insider bought their own stock with their own money; that is the signal everything else here is built around.
Window aggregates
Common stock onlyInsider Buy Volume
$6.7B
1,902 acquisitions · $594.9M open-market
Derivative rows are excluded from these totals — one option exercise reports as both a derivative disposal and a stock acquisition, so counting both would double-inflate each side. Every row still appears in the feed, badged Deriv.
Sector Accumulation Map
Where insider money is moving across the tracked universe
net sellingbalancednet buying
How to read this
Each tile is one GICS sector. Two things are encoded, and they answer different questions:
- Tile size
- Total insider dollars that moved in that sector — buys plus sells. Bigger tile means more money changed hands, in either direction.
- Tile colour
- Net direction. Green is net buying, red is net selling, and the depth of the colour tracks how one-sided it was — a sector that is 51% buying looks almost grey, one that is 95% buying is vivid.
- ⚡ badge
- Cluster buys in that sector — issuers where two or more different insiders bought on the open market. The rarest and most actionable pattern this app detects.
Size is insider notional, not market cap. This app has no shares-outstanding source, and sizing by market cap would draw the same sectors at the same size every day regardless of what insiders actually did — which is the opposite of what this chart is for.
Only issuers in the tracked universe carry a sector, so anything outside it is counted separately and named beneath the map rather than silently dropped. Click any tile to filter the tape to that sector.
386 issuers in the current window are outside the tracked universe and carry no sector, so they are not mapped here.
Universe
150 of 660 tracked tickers active · 409 off-universe
Insider Trades Feed
120 transactions · sourced from Form 4 filings
How to read this
Every row is one line from a Form 4 — the filing a company insider must submit within two business days of trading their own company's stock. Straight from SEC EDGAR, parsed and priced.
Most insider "buying" is not buying. Grants and option exercises are compensation, not someone spending their own money, and they dominate the raw count. The Open market only filter reduces this to code P — the transactions that actually cost the insider something.
- Open market (code P)
- A real purchase at market prices with the insider's own cash. The only buy type this app treats as conviction.
- Grant / Award (code A)
- Shares handed over as compensation. Free to the recipient, and routinely issued to a dozen executives on the same day.
- Exercise (code M)
- Converting options into shares at a pre-agreed price. Often followed immediately by a sale.
- Deriv badge
- A derivative leg — an option or convertible rather than common stock. Excluded from the volume totals, because one exercise reports twice and would double-count.
- 10b5-1 badge
- The trade was made under a plan scheduled in advance, when the insider was barred from holding inside information. It moved shares but expresses no view about today — the Discretionary only filter removes these.
- ⚡ Cluster
- Two or more different insiders bought the same issuer on the open market. Rare, and the strongest pattern here — one person can be wrong about their own company; three at once is harder to dismiss.
- Proven / Weak record
- On an open-market buy, how this insider's OWN past buys did over the 90 days after each one, versus the S&P 500. Proven means a reliable sample that beat the market; Weak means one that lagged. It is history, not a forecast — see the Proven Buyers view for the full board.
| Insider | Ticker | Transaction | Price | ||||
|---|---|---|---|---|---|---|---|
President & CEO · Director | FLEXSTEEL INDUSTRIES INC $80.60 -0.97%▲50d · GC · +43% 3m | Tax withholding Common Stock | 11.9K 178.3K held | $78.17 | $926.9K | — | |
President & COO | THERMO FISHER SCIENTIFIC INC. $629.27 +0.27%▲50d · GC · +40% 3m | Option exercise10b5-1 Common Stock | 3.7K 26.9K held | $309.63 +103.2% since | $1.2M | — | |
President & COO | THERMO FISHER SCIENTIFIC INC. $629.27 +0.27%▲50d · GC · +40% 3m | Open-market saleOpen mkt10b5-1 Common Stock | 3.7K 23.2K held | $614.38 | $2.3M | — | |
Chief Executive Officer · Director | MICROSOFT CORP $487.31 +0.84%▲50d · +17% 3m | Tax withholding Common Stock | 70.5K 573.3K held | $513.53 | $36.2M | — | |
10% Owner | SONIDA SENIOR LIVING, INC. $39.38 -0.46%▼50d · GC · +6% 3m | Open-market saleOpen mkt Common Stock | 21.8K 202.6K held | $38.16 | $831.6K | — | |
10% Owner | SONIDA SENIOR LIVING, INC. $39.38 -0.46%▼50d · GC · +6% 3m | Open-market saleOpen mkt Common Stock | 97.6K 100.4K held | $38.42 | $3.7M | — | |
Chief Accounting Officer | COHERENT CORP. $277.83 -0.49%▼50d · GC · -23% 3m | Tax withholding Common Stock | 2.2K 24.2K held | $295.39 | $642.2K | — | |
Director | Concentra Group Holdings Parent, Inc. $33.74 -1.52%▲50d · GC · +34% 3m | Disposition to issuer Common Stock | 770K 4.7M held | $34.65 | $26.7M | — | |
Director | Concentra Group Holdings Parent, Inc. $33.74 -1.52%▲50d · GC · +34% 3m | Disposition to issuer Common Stock | 150K 882.1K held | $34.65 | $5.2M | — | |
Director | Concentra Group Holdings Parent, Inc. $33.74 -1.52%▲50d · GC · +34% 3m | Disposition to issuer Common Stock | 30K 196.3K held | $34.65 | $1M | — | |
Director | Concentra Group Holdings Parent, Inc. $33.74 -1.52%▲50d · GC · +34% 3m | Disposition to issuer Common Stock | 30K 196.3K held | $34.65 | $1M | — | |
Director | Concentra Group Holdings Parent, Inc. $33.74 -1.52%▲50d · GC · +34% 3m | Disposition to issuer Common Stock | 20K 206.3K held | $34.65 | $693K | — | |
Special Advisor to CEO | Freedom Holding Corp. $170.66 +4.26%▲50d · GC · +16% 3m | Open-market saleOpen mkt Common Stock | 14.4K 24.2K held | $158.27 | $2.3M | — | |
Chief Executive Officer | CATERPILLAR INC $811.02 -2.04%▼50d · GC · -8% 3m | Option exerciseDeriv Employee Stock options | 44.4K | $219.76 | $9.8M | — | |
Chief Executive Officer | CATERPILLAR INC $811.02 -2.04%▼50d · GC · -8% 3m | Option exercise Common Stock | 44.4K 79K held | $219.76 +269.0% since | $9.8M | — | |
Chief Executive Officer | CATERPILLAR INC $811.02 -2.04%▼50d · GC · -8% 3m | Tax withholding Common Stock | 12K 67K held | $812.98 | $9.8M | — | |
Chief Executive Officer | CATERPILLAR INC $811.02 -2.04%▼50d · GC · -8% 3m | Open-market saleOpen mkt Common Stock | 2.6K 50.9K held | $808.20 | $2.1M | — | |
Chief Executive Officer | CATERPILLAR INC $811.02 -2.04%▼50d · GC · -8% 3m | Open-market saleOpen mkt Common Stock | 2.1K 48.7K held | $809.08 | $1.7M | — | |
Chief Executive Officer | CATERPILLAR INC $811.02 -2.04%▼50d · GC · -8% 3m | Open-market saleOpen mkt Common Stock | 3K 45.7K held | $810.31 | $2.5M | — | |
Chief Executive Officer | CATERPILLAR INC $811.02 -2.04%▼50d · GC · -8% 3m | Open-market saleOpen mkt Common Stock | 5K 40.7K held | $811.31 | $4.1M | — | |
Chief Executive Officer | CATERPILLAR INC $811.02 -2.04%▼50d · GC · -8% 3m | Open-market saleOpen mkt Common Stock | 1.3K 39.4K held | $812.09 | $1M | — | |
Chief Executive Officer | CATERPILLAR INC $811.02 -2.04%▼50d · GC · -8% 3m | Open-market saleOpen mkt Common Stock | 4.8K 34.6K held | $813.72 | $3.9M | — | |
Chief Executive Officer | CATERPILLAR INC $811.02 -2.04%▼50d · GC · -8% 3m | Open-market saleOpen mkt Common Stock | 750 64.9K held | $803.39 | $602.5K | — | |
Chief Executive Officer | CATERPILLAR INC $811.02 -2.04%▼50d · GC · -8% 3m | Open-market saleOpen mkt Common Stock | 1.4K 63K held | $805.36 | $1.1M | — | |
Chief Executive Officer | CATERPILLAR INC $811.02 -2.04%▼50d · GC · -8% 3m | Open-market saleOpen mkt Common Stock | 3.4K 59.7K held | $806.31 | $2.7M | — | |
Chief Executive Officer | CATERPILLAR INC $811.02 -2.04%▼50d · GC · -8% 3m | Open-market saleOpen mkt Common Stock | 6.1K 53.5K held | $807.41 | $5M | — | |
10% Owner | REPUBLIC SERVICES, INC. $220.67 +0.53%▲50d · GC · +6% 3m | Open-market buyOpen mkt Common stock | 58.5K 114M held | $220.29 +0.2% since | $12.9M | — | |
10% Owner | REPUBLIC SERVICES, INC. $220.67 +0.53%▲50d · GC · +6% 3m | Open-market buyOpen mkt Common stock | 124K 114.1M held | $220.77 -0.0% since | $27.4M | — | |
10% Owner | REPUBLIC SERVICES, INC. $220.67 +0.53%▲50d · GC · +6% 3m | Open-market buyOpen mkt Common stock | 68.9K 114.2M held | $222.12 -0.7% since | $15.3M | — | |
10% Owner | REPUBLIC SERVICES, INC. $220.67 +0.53%▲50d · GC · +6% 3m | Open-market buyOpen mkt Common stock | 155.9K 114.3M held | $221.32 -0.3% since | $34.5M | — | |
10% Owner | REPUBLIC SERVICES, INC. $220.67 +0.53%▲50d · GC · +6% 3m | Open-market buyOpen mkt Common stock | 102.2K 114.4M held | $222.30 -0.7% since | $22.7M | — | |
10% Owner | REPUBLIC SERVICES, INC. $220.67 +0.53%▲50d · GC · +6% 3m | Open-market buyOpen mkt Common stock | 41.7K 114.5M held | $223.30 -1.2% since | $9.3M | — | |
Chairperson & CEO · Director | UNITED THERAPEUTICS Corp $513.12 -1.51%▼50d · GC · -9% 3m | Option exercise10b5-1 Common Stock | 9.5K 333.9K held | $135.42 +278.9% since | $1.3M | — | |
Chairperson & CEO · Director | UNITED THERAPEUTICS Corp $513.12 -1.51%▼50d · GC · -9% 3m | Open-market saleOpen mkt10b5-1 Common Stock | 4.2K 327.5K held | $510.93 | $2.2M | — | |
Chairperson & CEO · Director | UNITED THERAPEUTICS Corp $513.12 -1.51%▼50d · GC · -9% 3m | Open-market saleOpen mkt10b5-1 Common Stock | 1.6K 325.9K held | $511.75 | $818.8K | — | |
10% Owner | ORTHOPEDIATRICS CORP $25.07 -2.26%▲50d · GC · +36% 3m | Open-market saleOpen mkt Common Stock | 326.7K 6.5M held | $23.04 | $7.5M | — | |
Chief Strategy Officer · Director | Airbnb, Inc. $187.30 +1.24%▲50d · GC · +40% 3m | Open-market saleOpen mkt10b5-1 Class A Common Stock | 45.2K 32.5K held | $190.58 | $8.6M | — | |
Chief Strategy Officer · Director | Airbnb, Inc. $187.30 +1.24%▲50d · GC · +40% 3m | Open-market saleOpen mkt10b5-1 Class A Common Stock | 11.9K 20.6K held | $191.20 | $2.3M | — | |
Chief Strategy Officer · Director | Airbnb, Inc. $187.30 +1.24%▲50d · GC · +40% 3m | Open-market saleOpen mkt10b5-1 Class A Common Stock | 4K 28.3K held | $186.38 | $753.4K | — | |
Chief Strategy Officer · Director | Airbnb, Inc. $187.30 +1.24%▲50d · GC · +40% 3m | Open-market saleOpen mkt10b5-1 Class A Common Stock | 3.7K 24.5K held | $187.68 | $699.7K | — | |
Chief Strategy Officer · Director | Airbnb, Inc. $187.30 +1.24%▲50d · GC · +40% 3m | Open-market saleOpen mkt10b5-1 Class A Common Stock | 3.7K 20.8K held | $188.51 | $701.1K | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 172.3K | $59.81 | $10.3M | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 195.6K | $62.39 | $12.2M | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 259.1K | $69.71 | $18.1M | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 244.2K | $64.98 | $15.9M | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 287.7K | $65.36 | $18.8M | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 240K | $41.49 | $10M | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 313K | $48.14 | $15.1M | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 228K | $41.21 | $9.4M | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 248K 176.7K held | $85.00 | $21.1M | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 80K | $85.00 | $6.8M | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 176.7K | $85.00 | $15M | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 136.8K | $85.00 | $11.6M | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 106K | $85.00 | $9M | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 110K | $85.00 | $9.4M | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 100K | $85.00 | $8.5M | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 111.1K | $85.00 | $9.4M | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 111.1K | $85.00 | $9.4M | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 111.1K | $85.00 | $9.4M | — | |
President & CEO · Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 111.1K | $85.00 | $9.4M | — | |
Chief Financial & Infra. Ofcr. | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 80K | $51.25 | $4.1M | — | |
Chief Financial & Infra. Ofcr. | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 50K | $41.21 | $2.1M | — | |
Chief Financial & Infra. Ofcr. | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 8K 71.5K held | $85.00 | $676.3K | — | |
Chief Financial & Infra. Ofcr. | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 71.5K | $85.00 | $6.1M | — | |
Chief Scientific Officer | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 87K | $41.49 | $3.6M | — | |
Chief Scientific Officer | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 65K | $48.14 | $3.1M | — | |
Chief Scientific Officer | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 47K | $41.21 | $1.9M | — | |
Chief Scientific Officer | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 90.5K | $83.09 | $7.5M | — | |
Chief Scientific Officer | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 74.5K | $75.72 | $5.6M | — | |
Chief Scientific Officer | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 56.3K | $59.81 | $3.4M | — | |
Chief Scientific Officer | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 60K | $62.39 | $3.7M | — | |
Chief Scientific Officer | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 85K | $69.71 | $5.9M | — | |
Chief Scientific Officer | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 15K | $61.81 | $927.2K | — | |
Chief Scientific Officer | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 77K | $64.98 | $5M | — | |
Chief Scientific Officer | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 110K | $65.36 | $7.2M | — | |
Chief Scientific Officer | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 58.3K 79.7K held | $85.00 | $5M | — | |
Chief Scientific Officer | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 79.7K | $85.00 | $6.8M | — | |
Chief Commercial Officer | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 97.5K | $44.41 | $4.3M | — | |
Chief Commercial Officer | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 55K | $41.21 | $2.3M | — | |
Chief Commercial Officer | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 34K | $85.00 | $2.9M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 25K | $68.92 | $1.7M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 17.5K | $64.77 | $1.1M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 17.5K | $66.71 | $1.2M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 17.5K | $64.68 | $1.1M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 16.3K 5.9K held | $85.00 | $1.4M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 35K | $65.70 | $2.3M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 17.5K | $64.68 | $1.1M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 16.3K 5.9K held | $85.00 | $1.4M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 17.5K | $64.68 | $1.1M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 22.8K 5.9K held | $85.00 | $1.9M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 12.5K | $61.76 | $772K | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 12.5K | $61.77 | $772.1K | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 17.5K | $64.77 | $1.1M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 17.5K | $66.71 | $1.2M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 17.5K | $64.68 | $1.1M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 16.3K 5.9K held | $85.00 | $1.4M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 25K | $60.85 | $1.5M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 12.5K | $61.77 | $772.1K | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 17.5K | $64.77 | $1.1M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 17.5K | $64.68 | $1.1M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 35K | $56.69 | $2M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 17.5K | $64.68 | $1.1M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 13.3K 5.9K held | $85.00 | $1.1M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 12.5K | $61.76 | $772K | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 12.5K | $61.77 | $772.1K | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 17.5K | $64.77 | $1.1M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 17.5K | $66.71 | $1.2M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuerDeriv Stock Option (Right to Buy) | 17.5K | $64.68 | $1.1M | — | |
Director | Crinetics Pharmaceuticals, Inc. $84.95 +0.13%▲50d · GC · +146% 3m | Disposition to issuer Common Stock | 116.1K 5.9K held | $85.00 | $9.9M | — | |
Chief Financial Officer | RHYTHM PHARMACEUTICALS, INC. $110.00 +0.99%▲50d · GC · +22% 3m | Option exercise10b5-1 Common Stock | 57.2K 176.8K held | $25.79 +326.5% since | $1.5M | — | |
Chief Financial Officer | RHYTHM PHARMACEUTICALS, INC. $110.00 +0.99%▲50d · GC · +22% 3m | Open-market saleOpen mkt10b5-1 Common Stock | 23.1K 153.7K held | $104.59 | $2.4M | — | |
Chief Financial Officer | RHYTHM PHARMACEUTICALS, INC. $110.00 +0.99%▲50d · GC · +22% 3m | Open-market saleOpen mkt10b5-1 Common Stock | 11.5K 142.2K held | $105.37 | $1.2M | — | |
Chief Financial Officer | RHYTHM PHARMACEUTICALS, INC. $110.00 +0.99%▲50d · GC · +22% 3m | Open-market saleOpen mkt10b5-1 Common Stock | 28.2K 114K held | $106.20 | $3M | — | |
EVP & Chief Financial Officer | HALLIBURTON CO $35.34 -0.98%▲50d · -16% 3m | Open-market saleOpen mkt10b5-1 Common Stock | 24.8K 124.1K held | $37.50 | $929.1K | — | |
CEO · Director | BILL Holdings, Inc. $49.23 -2.15%▲50d · GC · +25% 3m | Tax withholding Common Stock | 24.9K 141.3K held | $50.31 | $1.3M | — | |
Director | EverCommerce Inc. $9.64 -0.41%▼50d · -8% 3m | Tax withholding Common Stock | 212.2K 5.1M held | $10.61 | $2.3M | — | |
10% Owner | Flywire Corp $19.54 +4.21%▲50d · GC · +21% 3m | Open-market saleOpen mkt Voting common stock, $0.0001 par value per share | 37K 11.1M held | $18.78 | $695K | — | |
Chief Executive Officer · Director | Chime Financial, Inc. $32.78 +2.60%▲50d · GC · +81% 3m | Open-market saleOpen mkt10b5-1 Class A Common Stock | 88.6K | $34.03 | $3M | — | |
Chief Financial Officer | BILL Holdings, Inc. $49.23 -2.15%▲50d · GC · +25% 3m | Tax withholding10b5-1 Common Stock | 28.6K 33.5K held | $50.31 | $1.4M | — | |
Chief Financial Officer | BILL Holdings, Inc. $49.23 -2.15%▲50d · GC · +25% 3m | Open-market saleOpen mkt10b5-1 Common Stock | 29.6K 3.9K held | $47.80 | $1.4M | — |
FLXS
TMO
MSFT
SNDA
COHR
CON
FRHC
CAT
RSG
UTHR
KIDS
ABNB
CRNX
RYTM
HAL
BILL
EVCM
FLYW
CHYMSchmidt Derek P
President & CEO · Director
Tax withholding
Shares
11.9K
Price
$78.17
Value
$926.9K
FLEXSTEEL INDUSTRIES INC▲50d · GC · +43% 3m$80.60—
Pettiti Gianluca
President & COO
Option exercise10b5-1
Shares
3.7K
Price
$309.63
+103.2% since
Value
$1.2M
THERMO FISHER SCIENTIFIC INC.▲50d · GC · +40% 3m$629.27—
Pettiti Gianluca
President & COO
Open-market saleOpen mkt10b5-1
Shares
3.7K
Price
$614.38
Value
$2.3M
THERMO FISHER SCIENTIFIC INC.▲50d · GC · +40% 3m$629.27—
Nadella Satya
Chief Executive Officer · Director
Tax withholding
Shares
70.5K
Price
$513.53
Value
$36.2M
MICROSOFT CORP▲50d · +17% 3m$487.31—
Simanovsky Michael
10% Owner
Open-market saleOpen mkt
Shares
21.8K
Price
$38.16
Value
$831.6K
SONIDA SENIOR LIVING, INC.▼50d · GC · +6% 3m$39.38—
Simanovsky Michael
10% Owner
Open-market saleOpen mkt
Shares
97.6K
Price
$38.42
Value
$3.7M
SONIDA SENIOR LIVING, INC.▼50d · GC · +6% 3m$39.38—
Mocciaro Ilaria
Chief Accounting Officer
Tax withholding
Shares
2.2K
Price
$295.39
Value
$642.2K
COHERENT CORP.▼50d · GC · -23% 3m$277.83—
Ortenzio Robert A
Director
Disposition to issuer
Shares
770K
Price
$34.65
Value
$26.7M
Concentra Group Holdings Parent, Inc.▲50d · GC · +34% 3m$33.74—
Ortenzio Robert A
Director
Disposition to issuer
Shares
150K
Price
$34.65
Value
$5.2M
Concentra Group Holdings Parent, Inc.▲50d · GC · +34% 3m$33.74—
Ortenzio Robert A
Director
Disposition to issuer
Shares
30K
Price
$34.65
Value
$1M
Concentra Group Holdings Parent, Inc.▲50d · GC · +34% 3m$33.74—
Ortenzio Robert A
Director
Disposition to issuer
Shares
30K
Price
$34.65
Value
$1M
Concentra Group Holdings Parent, Inc.▲50d · GC · +34% 3m$33.74—
Ortenzio Robert A
Director
Disposition to issuer
Shares
20K
Price
$34.65
Value
$693K
Concentra Group Holdings Parent, Inc.▲50d · GC · +34% 3m$33.74—
Ler Evgeny
Special Advisor to CEO
Open-market saleOpen mkt
Shares
14.4K
Price
$158.27
Value
$2.3M
Freedom Holding Corp.▲50d · GC · +16% 3m$170.66—
Creed Joseph E
Chief Executive Officer
Option exerciseDeriv
Shares
44.4K
Price
$219.76
Value
$9.8M
CATERPILLAR INC▼50d · GC · -8% 3m$811.02—
Creed Joseph E
Chief Executive Officer
Option exercise
Shares
44.4K
Price
$219.76
+269.0% since
Value
$9.8M
CATERPILLAR INC▼50d · GC · -8% 3m$811.02—
Creed Joseph E
Chief Executive Officer
Tax withholding
Shares
12K
Price
$812.98
Value
$9.8M
CATERPILLAR INC▼50d · GC · -8% 3m$811.02—
Creed Joseph E
Chief Executive Officer
Open-market saleOpen mkt
Shares
2.6K
Price
$808.20
Value
$2.1M
CATERPILLAR INC▼50d · GC · -8% 3m$811.02—
Creed Joseph E
Chief Executive Officer
Open-market saleOpen mkt
Shares
2.1K
Price
$809.08
Value
$1.7M
CATERPILLAR INC▼50d · GC · -8% 3m$811.02—
Creed Joseph E
Chief Executive Officer
Open-market saleOpen mkt
Shares
3K
Price
$810.31
Value
$2.5M
CATERPILLAR INC▼50d · GC · -8% 3m$811.02—
Creed Joseph E
Chief Executive Officer
Open-market saleOpen mkt
Shares
5K
Price
$811.31
Value
$4.1M
CATERPILLAR INC▼50d · GC · -8% 3m$811.02—
Creed Joseph E
Chief Executive Officer
Open-market saleOpen mkt
Shares
1.3K
Price
$812.09
Value
$1M
CATERPILLAR INC▼50d · GC · -8% 3m$811.02—
Creed Joseph E
Chief Executive Officer
Open-market saleOpen mkt
Shares
4.8K
Price
$813.72
Value
$3.9M
CATERPILLAR INC▼50d · GC · -8% 3m$811.02—
Creed Joseph E
Chief Executive Officer
Open-market saleOpen mkt
Shares
750
Price
$803.39
Value
$602.5K
CATERPILLAR INC▼50d · GC · -8% 3m$811.02—
Creed Joseph E
Chief Executive Officer
Open-market saleOpen mkt
Shares
1.4K
Price
$805.36
Value
$1.1M
CATERPILLAR INC▼50d · GC · -8% 3m$811.02—
Creed Joseph E
Chief Executive Officer
Open-market saleOpen mkt
Shares
3.4K
Price
$806.31
Value
$2.7M
CATERPILLAR INC▼50d · GC · -8% 3m$811.02—